RxDoctor Payments Data

Jennifer Sasaki, MD

Surgical Oncology · Houston, TXNPI 1467718775

Payments from drug & device makers

$261in general payments, 2019–2025

Across 11 payments — averaging $23.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanara Medtech Inc.$41
  • Myriad Genetic Laboratories, Inc.$39
  • Axogen$39
  • Tactile Systems Technology Inc$35
  • Acera Surgical, Inc.$25
  • Hologic Sales And Service, LLC$25
  • plus $57 from 3 others

What the payments were for

  • Food & beverage$261100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$261 in reported general payments places this provider in the 20th percentile of 191 surgical oncology providers in Texas.

See all surgical oncology providers in Texas

Medicare billing

Part B allowed, 2024
$37,180
Medicare patients
117
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tramadol Hcl70$99

Paid to pharmacies, not to this prescriber.

Other surgical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →